Laurentia G.
- Country
- Romania
- Department
- Oncology
Research Overview
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- Pharmacokinetics Study Comparing GME751 and US/EU-Approved Pembrolizumab in Stage II and III Melanoma Patients Requiring Adjuvant Therapy
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 176 of 447 partner sites.
Specializations
Melanoma Research
This investigator specializes in advanced melanoma treatment, with particular focus on adjuvant therapy for patients with surgically treated melanoma.
- Stage IIB and IIC Melanoma Management
- Stage III Melanoma Treatment
- Post-surgical Therapeutic Approaches
The research involves evaluation of therapeutic options for patients following complete tumor resection.
Hematologic Oncology
The investigator conducts research in blood-related malignancies, focusing on innovative treatments for various hematologic conditions.
- Acute Myeloid Lymphoma (AML)
- Myelodysplastic Syndrome (MDS)
- Combined Therapeutic Approaches
Special attention is given to patients with varying levels of organ function impairment.
Solid Tumor Studies
The investigator explores treatments for advanced solid tumors, including novel therapeutic combinations and targeted approaches.
- Locally Advanced Tumors
- Metastatic Disease
- Immunotherapy Applications
Research encompasses various stages of solid tumor progression and treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.